FIELD: chemistry.
SUBSTANCE: invention relates to substituted N-phenylbipyrrolidine carboxamides of formula , where values of R, R1, R2, R3 and R4 are given in claim 1.
EFFECT: compounds have activity which binds to the H3 ligand, which allows use thereof in pharmaceutical compositions for treating sleep disorder.
10 cl, 1 tbl, 4 dwg, 153 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED N-PHENYLBIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF | 2008 |
|
RU2477720C2 |
SUBSTITUTED N-PHENYL-BIPYRROLIDINE UREAS AND THERAPEUTIC USE THEREOF | 2008 |
|
RU2478094C2 |
SUBSTITUTED N-PHENYLPYRROLIDINYL METHYLPYRROLIDINE AMIDES AND THERAPEUTIC USE THEREOF AS MODULATORS OF HISTAMINE H3 RECEPTOR | 2008 |
|
RU2477721C2 |
SUBSTITUTED TETRAHYDROPYRANSPIROPYRROLIDINONE AND TETRAHYDROPYRANSPIROPIPERIDINONE, BASED ON THEM PHARMACEUTICAL COMPOSITION AND APPLICATION FOR THERAPEUTIC PURPOSES | 2009 |
|
RU2519778C2 |
HETEROARYL COMPOUNDS AS BTK INHIBITORS AND USE THEREOF | 2014 |
|
RU2703301C2 |
HETEROARYL COMPOUNDS AS TKB INHIBITORS AND USE THEREOF | 2015 |
|
RU2742122C2 |
PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS | 2006 |
|
RU2420519C2 |
PYRIMIDINE DERIVATIVES WITH ACTIVITY TOWARDS MCH | 2005 |
|
RU2373197C2 |
NOVEL 4-AMINO-N-HYDROXYBENZAMIDES AS HDAC INHIBITORS FOR TREATING CANCER | 2012 |
|
RU2591190C2 |
ANTHRANYLAMIDEPYRIDINE AMIDES WITH SELECTIVE EFFECT AS INHIBITORS OF VEGFR-2 AND VEGFR-3 | 2002 |
|
RU2299208C2 |
Authors
Dates
2013-03-20—Published
2008-10-14—Filed